Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table
Year: 2024
Type: review
Source: Journal of clinical lipidology
Institutions: University Hospital of Geneva, University Medical Center Utrecht, Pfizer (United States), Amgen (Switzerland), Daiichi Sankyo (Germany), Imperial College London, Hospital Universitari Germans Trias i Pujol, Leiden University Medical Center, Netherlands Heart Institute, University Hospital Leipzig, Hospital Universitario Ramón y Cajal, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Maastricht University, Hacettepe University, University of Glasgow, Brigham and Women's Hospital
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: European Society of Cardiology
OpenAlex ID: W4400390730